N/A
Completed N=6,139
Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
Source: ClinicalTrials.gov NCT01332357 ↗Enrolled (actual)
6,139
Serious AEs
—
Results posted
Oct 2011
Primary outcomePrimary: Number of Participants With an Asthma-related Event Occurring Between 1 and 6 Months Following the Index Event — 915 participants — p=<0.0001
Summary
The objective of this study is to compare readmission to the emergency department for asthma in asthma patients who receive treatment with fluticasone propionate and salmeterol oral inhaler after an initial emergency department visit using a retrospective observational cohort study design.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With an Asthma-related Event Occurring Between 1 and 6 Months Following the Index Event |
915 | <0.0001 sig |
Eligibility Criteria
Inclusion Criteria
- Subjects with asthma as determined by ICD-9 codes and asthma drug use
- at least 12 years of age
- discharged from an initial Emergency Department visit within 12 months
Exclusion Criteria
- Subjects with COPD or treatment for COPD
Data sourced from ClinicalTrials.gov (NCT01332357). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.